Top of page

Capital Markets

Practice

Filters

Royalty Pharma $2.5 billion IPO

Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering…

Credicorp $500 million notes offering

Davis Polk advised Credicorp Ltd. in connection with its $500 million offering of 2.750% notes due 2025, which were issued…

Liberty Media rights offering

Davis Polk advised the dealer manager in connection with an SEC-registered rights offering by Liberty Media Corporation. A…

Generation Bio $230 million IPO

Davis Polk advised the representatives of the underwriters in connection with the $230 million initial public offering…
Back to top